Thank you for reading the news about Museum of Happiness opens in Riyadh and now with the details
Jeddah - Yasmine El Tohamy - JEDDAH: King Abdullah International Medical Research Center (KAIMRC) in Saudi Arabia is preparing to take part in advanced trials of one or two COVID-19 vaccines.
About 40 potential vaccines are being tested on humans, nine of which are at the advanced stage of clinical trials to evaluate their safety and effectiveness in protecting people against a virus that has infected more than 31 million people around the world.
The center confirmed its readiness to cooperate with the Kingdom’s Ministry of Health and the Saudi Food and Drug Authority (SFDA) and participate in tests of one or two of the nine vaccines that are in the third phase of clinical trials, during which large-scale testing on humans takes place.
Dr. Naif Al-Harbi, the head of KAIMRC’s drug-development unit, told Al-Ekhbariya TV news channel that it is unprecedented to have nine vaccines in stage three of clinical trials so soon, less than a year, after the emergence of a new virus.
“Approval or disapproval of any drug normally follows the third stage of its clinical trials, which is the last stage,” he added. “Since the pandemic, KAIMRC has been in continuous contact with a number of drug companies in four countries (that are developing vaccines).”
KAIMRC has been working with one Chinese pharmaceutical company in particular to help evaluate and accelerate the development of its vaccine, he said.
“Over the past two months, we have been in contact with Sinovac to scientifically evaluate its product, in term of the tests on animals and a study of the results of stages one and two on humans,” Al-Harbi said.
He added that the Kingdom’s Ministry of Health is working with a different Chinese company to evaluate whether the vaccine it is developing is effective. A number of factors are taken into consideration when reaching a conclusion.
“We examine the drugs and make sure they have caused no side effects when tested on humans, or that they just caused insignificant side effects,” said Al-Harbi. “We also look into the manufacturing company’s profile to ensure it follows the standards of the good manufacturing practices, and that the company’s products are consistently produced and controlled according to quality standards.”
He added that SFDA is also doing a great job in ensuring that vaccines are safe, to avoid any risks to the health of people in the Kingdom.
In a message posted on Twitter, KAIMRC said that some countries, such as Russia, China and the UAE, have given doctors the green light to use some vaccines on patients before that have been approved, but only in emergency cases and when the results of early clinical studies indicate that the vaccine is safe.
On Monday, Saudi Arabia announced 27 additional COVID-19-related deaths. The death toll in the country now stands at 4,512.
Meanwhile, 492 new cases have been confirmed in the Kingdom, bringing the total number of people infected by the virus to 330,246. Of those, 14,235 cases remain active and 1,133 patients are in a critical condition.
The Ministry of Health said Makkah recorded the highest number of new cases, with 58, followed by Jeddah with 53, and Madinah with 38.
A further 1,060 people in the Kingdom have recovered from COVID-19, bringing the total number of recoveries to 311,499. A total of 6,093,601 tests for the virus have been carries out in the country, including 43,652 in the past 24 hours.
These were the details of the news Museum of Happiness opens in Riyadh for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Arab News and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.